[Expression Changes of Serum Transferrin Receptor and Its Mechanism in Children with Acute Leukemia]

She-An Chen1, Wen-Bin Zhang2

  • 1Department of Clinical Laboratorial Examination, Foshan first people's Hospital, Foshan 528000, Guangdong Province,China.E-mail:chenshean56@163.com.

Insights

Serum transferrin receptor (sTFR) levels are elevated in children with acute leukemia (AL). Downregulating transferrin receptor (TFR) gene expression inhibits leukemia cell proliferation and division, offering a potential therapeutic strategy for AL.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Acute leukemia (AL) is a significant health concern in children.
  • Serum transferrin receptor (sTFR) is a marker associated with cell proliferation and iron metabolism.
  • Understanding the role of sTFR in pediatric AL is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the expression changes of serum transferrin receptor (sTFR) in children with acute leukemia (AL).
  • To explore the mechanism underlying sTFR expression in AL.
  • To evaluate the effect of transferrin receptor (TFR) gene silencing on leukemia cell proliferation and cell cycle.

Main Methods:

  • Comparative analysis of sTFR levels in pediatric AL patients and healthy controls.
  • Detection of TFR mRNA and protein expression in peripheral blood leukemic cells.
  • RNA interference (siRNA) to silence TFR genes in leukemia cell lines (KG-1a and TCHu147).
  • MTT assay and flow cytometry to assess cell proliferation and cell cycle distribution.
  • Western blot to analyze cyclin levels post-TFR gene silencing.

Main Results:

  • Children with AL exhibited significantly higher sTFR levels compared to healthy controls.
  • Elevated TFR mRNA and protein expression were observed in leukemic cells from AL patients.
  • sTFR levels correlated with white blood cell count, leukemic cell burden, hepcidin levels, and risk grade in AL patients.
  • TFR gene silencing significantly inhibited the proliferation of KG-1a and TCHu147 cells.
  • Flow cytometry revealed an increased G0/G1 phase cell ratio and a decreased G2/M phase cell ratio in TFR-silenced leukemia cells.

Conclusions:

  • Peripheral blood leukemic cells in AL patients synthesize increased TFR protein, leading to elevated sTFR levels.
  • Downregulating TFR gene expression effectively interferes with leukemia cell division.
  • Targeting TFR presents a promising therapeutic strategy for pediatric acute leukemia.
Abstract

Related Concept Videos

The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.8K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.5K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
4.1K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.0K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.0K